Results 161 to 170 of about 15,580 (201)

Impact of Allostatic Load on Chronic Hepatitis B and C: A Narrative Review. [PDF]

Cureus
Ogbu CE, Kalu JN, Ezechukwu M, Umerah C.
europepmc   +1 more source

Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis. [PDF]

Front Oncol
Wang Y, Wu JY, Xiang Q, Liao TF, Jiang XY, Chen J.   +5 more
europepmc   +1 more source

Hepatitis B virus and hepatitis D virus co-infection complicated by autoimmune hepatitis: Two case reports. [PDF]

World J Clin Cases
Dou J, Zhao XY, Wang ZG, Ning ZH, Wang XZ, Guo F.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Entecavir

Enfermedades Infecciosas y Microbiología Clínica, 2008
Chronic hepatitis B continues to be a serious problem worldwide. Because a high viral load is associated with greater progression to cirrhosis and hepatocarcinoma in these patients, new drugs that achieve rapid, potent and lasting suppression of viral replication must be sought.
José Luis, Calleja, Beatriz, Peñas
openaire   +2 more sources

Entecavir

Hospital Pharmacy, 2005
Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada, Terri Levien, Danial E. Baker   +2 more
openaire   +2 more sources

Entecavir

Reactions Weekly, 2015
  +7 more sources

Entecavir

Reactions Weekly, 2018
  +7 more sources

Entecavir

Reactions Weekly, 2014
  +6 more sources

Entecavir

Drugs, 2006
Ching-Lung Lai, Man-Fung Yuen
  +4 more sources